Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China flag China · Delayed Price · Currency is CNY
7.72
-0.33 (-4.10%)
May 12, 2026, 3:04 PM CST

SHE:300942 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
412.01392.84293.4481.75247.45342.21
Short-Term Investments
----181.91-
Trading Asset Securities
187.64235.3302.92120.03-340.21
Cash & Short-Term Investments
599.66628.13596.31601.78429.36682.42
Cash Growth
3.12%5.34%-0.91%40.16%-37.08%80.01%
Accounts Receivable
102.74111.3394.1176.284.0397.37
Other Receivables
5.124.42.123.3615.176.5
Receivables
107.86115.7496.2379.5699.2103.87
Inventory
62.2854.7740.4331.46100.6193.86
Other Current Assets
28.4619.1718.6424.8745.2517.49
Total Current Assets
798.26817.81751.62737.67674.42897.64
Property, Plant & Equipment
572.05578.27562.9426.52324.64143.44
Long-Term Investments
69.9283.52100.69145.18195.7621.94
Other Intangible Assets
36.8637.3539.2441.3942.442.6
Long-Term Accounts Receivable
----3.61-
Long-Term Deferred Tax Assets
9.747.050.083.0614.97.4
Long-Term Deferred Charges
1.140.541.681.9314.311.42
Other Long-Term Assets
--0.960.5912.4228.07
Total Assets
1,4881,5251,4571,3561,2821,153
Accounts Payable
44.7772.9658.7677.3565.1155.66
Accrued Expenses
15.6121.5923.0823.9439.4546.73
Short-Term Debt
1121----
Current Portion of Long-Term Debt
13.9813.5541.65.475.18-
Current Portion of Leases
---9.2818.614
Current Income Taxes Payable
3.725.60.050.010.019.74
Current Unearned Revenue
14.1817.1825.118.6566.6127.59
Other Current Liabilities
6.218.833.362.224.822.91
Total Current Liabilities
109.46160.7151.96136.93199.78156.63
Long-Term Debt
436.51413426.39345.7856.32-
Long-Term Leases
---5.3439.2527.12
Long-Term Unearned Revenue
40.541.096.516.5420.3322.19
Other Long-Term Liabilities
2.082.082.083.022.08-
Total Liabilities
588.54616.87586.92507.61317.75205.94
Common Stock
405.07405.07401.32400.86400.86400.86
Additional Paid-In Capital
221.58221.56190.22186.59178.7141.91
Retained Earnings
205.63215.89209.14192.02385.43402.28
Comprehensive Income & Other
61.3461.5668.3369.52-0.09-0.28
Total Common Equity
893.62904.08869.01848.99964.89944.76
Minority Interest
5.83.61.24-0.27-0.191.82
Shareholders' Equity
899.42907.68870.24848.73964.7946.58
Total Liabilities & Equity
1,4881,5251,4571,3561,2821,153
Total Debt
461.49447.55467.98365.87119.3441.12
Net Cash (Debt)
138.17180.59128.33235.91310.02641.31
Net Cash Growth
30.42%40.72%-45.60%-23.91%-51.66%69.17%
Net Cash Per Share
0.300.390.300.590.781.63
Filing Date Shares Outstanding
405.51628.23401.32400.86400.86400.86
Total Common Shares Outstanding
405.51628.23401.32400.86400.86400.86
Working Capital
688.8657.11599.66600.74474.64741.02
Book Value Per Share
2.201.442.172.122.412.36
Tangible Book Value
856.76866.73829.76807.6922.49902.16
Tangible Book Value Per Share
2.111.382.072.012.302.25
Buildings
--330.0315.8715.8710.24
Machinery
--87.0990.58106.5172.08
Construction In Progress
--199.79356.63190.8751.34
Source: S&P Global Market Intelligence. Standard template. Financial Sources.